Page of

Cervical Cancer Screening 

Cervical Cancer Screening
Chapter:
Cervical Cancer Screening
Source:
Psycho-Oncology (3 ed.)
Author(s):

Suzanne M. Miller

, Siu-kuen Azor Hui

, John Scarpato

, and Minsun Lee

DOI:
10.1093/med/9780199363315.003.0008

Cervical cancer is one of the most highly preventable cancers. Current evidence-based prevention strategies include (1) primary prevention of oncogenic human papillomavirus (HPV) infection through vaccination before sexual initiation in adolescents; (2) secondary prevention through cervical cancer screening using cervical cytology and/or testing for oncogenic HPV strains; and (3) management of pre-cancerous/early cancerous cervical lesions. Despite the overall decline of cervical cancer incidence and mortality rates worldwide, the developing countries and racial/ethnic minority populations in developed countries still bear a disproportionate burden of the disease. In the United States, this effect is largely due to low adherence rates to recommended screening and follow-up management regimens for abnormal test results. Psychosocial factors have been found to play a central role in facilitating or undermining patient adherence. Interventions developed to overcome access and psychosocial barriers have shown effectiveness in increasing adherence.

Sign In

Copyright © 2021. All rights reserved.